Invasive pulmonary aspergillosis: Effects of early resection in a neutropenic rat model

European Journal of Cardio-thoracic Surgery

Volumn 22, Issue 5, 2002, Pages 728-732

  Habicht, J M ^a,b   Preiss, M ^a   Passweg, J ^a   Dalquen, P ^a   Matt, P ^a   Adler, H ^a   Frei, R ^a   Zerkowski, H R ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b KLINIK HIRSLANDEN   (Switzerland)

Author keywords

Animal; Fungal infection; Invasive pulmonary aspergillosis; Neutropenia; Surgery

Indexed keywords

AMOXICILLIN; AMPHOTERICIN B DEOXYCHOLATE; CYCLOPHOSPHAMIDE; GENTAMICIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; INOCULATION; LEUKOCYTE COUNT; LOBECTOMY; LUNG ASPERGILLOSIS; MALE; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; RAT; SURGICAL MORTALITY; SURVIVAL RATE;

AMPHOTERICIN B; ANIMALS; ANTIBIOTICS, ANTIFUNGAL; ASPERGILLOSIS; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; LUNG DISEASES, FUNGAL; MALE; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL RATE;

EID: 0036843590     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(02)00467-0     Document Type: Article

References (25)

1. Denning D.W., Stevens D.A. Antifungal and surgical treatment of invasive aspergillosis: review of 2121 published cases. Rev Infect Dis. 12:1990;1147-1201.
2. Young V.K., Maghur H.A., Luke D.A., McGovern E.M. Operation for cavitating invasive pulmonary aspergillosis in immunocompromised patients. Ann Thorac Surg. 53:1992;621-624.
3. Wong K., Waters C.M., Walesby R.K. Surgical management of invasive pulmonary aspergillosis in immunocompromised patients. Eur J Cardiothorac Surg. 6:1992;138-143.
4. Moreau P., Zahar J.R., Milpied N., Baron O., Mahe B., Wu D., Germaud P., Despins P., Delajartre A.Y., Haroussea J.L. Localized invasive pulmonary aspergillosis in patients with neutropenia. Effectiveness of surgical resection. Cancer. 72:1993;3223-3226.
5. Robinson L.A., Reed E.C., Galbraith T.A., Alonso A., Moulton A.L., Fleming W.H. Pulmonary resection for invasive aspergillus infections in immunocompromised patients. J Thorac Cardiovasc Surg. 109:1995;1182-1197.
6. Caillot D., Casasnovas O., Bernard A., Couaillier J.F., Durand C., Cuisinier B., Solary E., Piard F., Petrella T., Bonnin A., Couillault G., Dumas M., Guy H. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol. 15:1997;139-247.
7. Baron O., Guillaumé B., Moreau P., Germaud P., Despins P., De Lajartre A.Y., Michaud J.L. Aggressive surgical management in localized pulmonary mycotic and nonmycotic infections for neutropenic patients with acute leukemia: report of eighteen cases. J Thorac Cardiovasc Surg. 115:1998;63-69.
8. Salerno C.T., Ouyang D.W., Pederson T.S., Larson D.M., Shake J.P., Johnson E.M., Maddaus M.A. Surgical therapy for pulmonary aspergillosis in immunocompromised patients. Ann Thorac Surg. 65:1998;1415-1419.
9. Reichenberger F., Habicht J.M., Kaim P., Dalquen P., Bernet F., Schlapfer R., Stulz P., Perruchoud A.P., Tichelli A., Gratwohl A., Tamm M. Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematologic diseases. Am J Respir Crit Care Med. 158:1998;885-890.
10. Habicht J.M., Matt P., Passweg J.R., Reichenberger F., Gratwohl A., Zerkowski H-R., Tamm M. Invasive pulmonary fungal infection in hematologic patients: is resection effective? Hematol J. 2:2001;250-256.
11. Leenders A.C.A.P., De Marie S., Ten Kate M.T., Bakker-Woudenberg I.A.J.M., Verbrugh H.A. Liposomal amphotericin B (Am Bisome) reduces dissemination of infection as compared with amphotericin B deoxycholate (Fungizone) in a rat model of pulmonary aspergillosis. J Antimicrob Chemother. 38:1996;215-225.
12. Van Etten E.W.M., Stearne-Cullen L.E.T., Ten Kate M.T., Bakker-Woudenberg I.A.J.M. Efficacy of liposomal Amphotericin B with prolonged circulation in blood in treatment of severe pulmonary aspergillosis in leukopenic rats. Antimicrob Agents Chemother. 44:2000;540-545.
13. McWhinney P.H.M., Kibbler C.C., Hamon M.D., Smith O.P., Gandhi L., Berger L.A., Walesby R.K., Hoffbrand A.V., Prentice H.G. Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience. Clin Infect Dis. 17:1993;397-404.
14. Morrison V.A., Haake R.J., Weisdorf D.J. Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome. Am J Med. 96:1994;497-503.
15. Barnes A.J., Oppenheim B.A., Chang J., Morgenstern G.R., Scarffe J.H. Early investigation and initiation of therapy for invasive pulmonary aspergillosis in leukaemic and bone marrow transplant patients. Mycoses. 42:1999;403-408.
16. Kami M., Tanaka Y., Kanda Y., Ogawa S., Masumoto T., Ohtomo K., Matsumura T., Saito T., Machida U., Kashima T., Hirai H. Computed tomographic scan of the chest, latex agglutination and plasma (1AE3)-beta-D-glucan assay in early diagnosis of invasive pulmonary aspergillosis: airways study of 215 patients. Haematologica. 85:2000;745-752.
17. Latgé J.P. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev. 12:1999;310-350.
18. Sobonya R.E. Fungal diseases, including allergic bronchopulmonary aspergillosis. Thurlbeck W.M., Pathology of the lung. 1995;307 Thieme Medical, New York.
19. Spreadbury C.L., Krausz T., Pervez S., Cohen J. Invasive aspergillosis: clinical and pathological features of a new animal model. J Med Vet Mycol. 27:1989;5-15.
20. Berenguer J., Ali N.M., Allende M.C., Lee J., Garrett K., Battaglia S., Piscitelli S.C., Rinaldi M.G., Pizzo P.A., Walsh T.J. Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A and correlation between therapeutic response and itraconazole concentrations in plasma. Antimicrob Agents Chemother. 38:1994;1303-1308.
21. Berenguer J., Allende M.C., Lee J.W., Garrett K., Lyman C., Ali N.M., Bacher J., Pizzo P.A., Walsh T.J. Pathogenesis of pulmonary aspergillosis: granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression. Am J Respir Crit Care Med. 152:1995;1079-1086.
22. Murphy M., Bernard E.M., Ishimaru T., Armstrong D. Activity of Voraconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother. 41:1997;696-698.
23. Dixon D.M., Polak A., Walsh T.J. Fungus dose-dependent primary pulmonary aspergillosis in immunosuppressed mice. Infect Immun. 57:1989;1452-1456.
24. Cenci E., Perito S., Enssle K.H., Mosci P., Latgé J.P., Romani L., Bistoni F. Th1 and Th2 cytokines in mice with invasive aspergillosis. Infect Immun. 65:1997;564-570.
25. Cenci E., Mencacci A., d'Ostiani C.F., Montagnoli C., Bacci A., Sero G.D., Perito S., Bistomni F., Romani L. Cytokine- and T-helper-dependent immunity in murine aspergillosis. Res Immunol. 149:1998;445-453.